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Neurological presentations of nutritional vitamin B12
deficiency in 42 breastfed infants in Southeast Turkey
Mustafa TAŞKESEN1, Ahmet YARAMIŞ2, Selahattin KATAR3, Ayfer GÖZÜ PİRİNÇÇİOĞLU1,
Murat SÖKER4

Aim: Nutritional vitamin B12 deficiency is common in developing and underdeveloped countries and has a wide variety
of neurological presentations. The aim of this study was to evaluate the neurological characteristics and laboratory
results of infants with vitamin B12 deficiency.
Materials and methods: A total of 42 infants were included in this study. All patients were evaluated for clinical,
physical, and neurological abnormalities, and an attempt was made to obtain short-term neurologic follow-up.
Results: Of 42 patients, 24 (57%) were boys and 18 (43%) were girls. The average age at diagnosis was 13.04 ± 5.68
months. Most of these infants were breastfed only and born from mothers with inadequate animal-derived protein
consumption. Hypotonia (100%), anorexia (92.8%), neurodevelopmental (85.7%), and social (80.9%) retardation were
the most present symptoms in all infants.
Conclusion: Severe neurological and hematological findings may be found in children with vitamin B12 deficiency.
Early diagnosis and treatment is crucial in cases of hematological complications and neurologic impairment. Neurologic
impairment may be irreversible if the diagnosis is delayed beyond 12 months. We think that dietary management, such
as nutritional support with vitamin B12 for the mothers during pregnancy and complementary food for infants, may
prevent the neurological deficits and neurodevelopmental retardation.
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Güneydoğu Anadolu’da anne sütü ile beslenen ve vitamin B12 eksikliği saptanan
çocuklarda nörolojik bulgular
Amaç: Beslenme yetersizliğine bağlı vitamin B12 eksikliği gelişmemiş ve gelişmekte olan ülkelerde yaygın olup, çeşitli
nörolojik sorunlara neden olmaktadır. Bu çalışmanın amacı vitamin B12 eksikliği tanısı ile izlenen süt çocuklarının
nörolojik bulgularını ve laboratuvar sonuçlarını değerlendirmektir.
Yöntem ve gereç: Çalışmaya 42 hasta alındı. Tüm hastaların klinik, fiziki ve nörolojik muayene sonuçları ve kısa süreli
izlem sonuçları kaydedildi.
Bulgular: Hastaların 24’ü (% 57) erkek ve 18’i (% 43) kız ve tanı sırasında ortalama yaşları 13,04 ± 5,68 ay idi. Hastaların
çoğunun sadece anne sütü ile beslendiği ve annelerinin hayvansal protein içeren gıdalardan yeterince tüketmedikleri
saptandı. En sık başvuru semptomları hipotoni (% 100), iştahsızlık (% 92,8), nörogelişimsel (% 85,7) ve sosyal gerilik
(% 80,9) idi.
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Sonuç: Vitamin B12 eksikliği olan çocuklarda ciddi nörolojik ve hematolojik bulgular görülebilir. Erken tanı ve tedavi,
hematolojik komplikasyonlar ve nörolojik etkilenme açısından önemlidir. Tanının gecikmesi (12 ay) durumunda
nörolojik etkilenme geri dönüşümsüz olabilmektedir. Gebelik döneminde annelere vitamin B12 desteği ve süt
çocuklarına tamamlayıcı besinlerin zamanında verilmesi nörolojik defisitlerin ve nörogelişimsel geriliğin oluşmasını
önleyebileceğini düşünmekteyiz.
Anahtar sözcükler: Nörolojik bulgu, hipotoni, beslenme, vitamin B12 eksikliği, süt çocukluğu

Introduction
Vitamin B12 is essential for development of the
central nervous system, and vitamin B12 deficiency
may cause severe impairment in only a few weeks (1).
Nutritional vitamin B12 deficiency occurs between 3
to 18 months of age, usually in children fed exclusively
with breast milk, due to undernutrition of the
mothers in underdeveloped or developing countries.
(2,3). The reason for maternal vitamin B12 deficiency
in these countries is low socioeconomic status, and
infants presenting with severe hematological and
neurological manifestations of vitamin B12 deficiency
are more common than formerly appreciated (4,5).
Nutritional vitamin B12 deficiency in
infancy may cause several neurological findings.
Neurological symptoms of vitamin B12 deficiency
are hetererogeneous and include muscular
hypotonia, irritability, lethargy, apathy, regression
of psychomotor development, tremor, ataxia, and
seizures (6,7).
Nutritional vitamin B12 deficiency is common
in our region and has been reported on in previous
studies (8-10). Late diagnosis of vitamin B12
deficiency and subsequent progression to severe
neurological damage are common. The aim of
the present study was to evaluate the neurological
presentations and treatment outcomes of hypotonic
infants with vitamin B12 deficiency.
Materials and methods
Between 2007 and 2010, a total of 42 patients with
neurological symptoms who had been diagnosed
with nutritional B12 vitamin deficiency were
enrolled in this study. All patients were evaluated
by clinical, physical, and neurological examinations.
Age, gender, nutritional history, initial symptoms,
socio-economical background of the family, physical
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examination findings; laboratory investigations,
including vitamin B12, homocysteine, and folic
acid levels of patients and their mothers, as well as
whole blood count, peripheral blood smear, serum
iron and iron binding capacity, serum and urinary
metabolic screening; and the results of the follow-up
examinations were recorded. All infants were assessed
for anemia, leukopenia, and thrombocytopenia. All
infants’ families had low socio-economic and cultural
status. The lower socio-cultural and economic
status of participants was established based on their
low education levels (uneducated) and household
income levels (under 300 US dollars per month). The
mothers of the patients were consuming insufficient
amounts of animal proteins. None of them had
followed-up regularly or received multivitamin
supplements during pregnancy. While 32 infants
were breast-fed only, 10 were both breast-fed and
given cow’s milk, but without any other supplemental
food. For all patients, a physical examination and
a Denver-II Developmental Screening Test were
performed. Peripheral blood smears were evaluated
by a pediatrician, whereas all other analyses were
performed by biochemists.
Hemoglobin concentration and leukocyte counts
vary by age. For this reason, in our patients, anemia
and leukopenia were defined as hemoglobin and
leukocyte counts of less than 11 g/dL, 6000/mm3
and a thrombocyte count below 150 × 10³/mm³, as
thrombocytopenia. Vitamin B12 and folate levels
were measured by electrochemiluminescence
immunoassay method (Cobas E601), and total
homocysteine level was measured by the competitive
chemiluminescent enzyme immunoassay method
(Immulyte 2500). Serum vitamin B12 levels lower
than 200 pg/mL and folate levels lower than 4 ng/mL
were accepted as deficiency, and a homocysteine level
higher than 12 mmol/L was accepted as deficiency in
infants (1,9,10).
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The patients were treated with intramuscular
vitamin B12: 50-100 μg every other day for 1 week,
twice weekly for 2 weeks, and once weekly for
another 2 weeks. Vitamin B12 was also administered
to mothers. The patients were followed-up and
outcomes of treatment were recorded. Vitamin B12
deficiency associated with Immerslund-Grasbeck
syndrome was eliminated by analysis of protein
in urine. Yet proteinuria was not detected in any
patient. Moreover, infants suffering from congenital,
metabolic or chronic disease or iron deficiency were
excluded from the study.
Results
Of the 42 patients 24 (57%) were boys, 18 (43%)
were girls, and the mean age of infants was 13.0 ±
5.6 months (range: 3-24). All infants were born from
mothers with inadequate animal-derived protein
consumption, and most of them were exclusively
breastfed. The percentiles (weight and height
measurements) of 29 infants (69%) were below the
3rd percentile for their age. All patients were from
lower socio-economical and cultural areas.
Hypotonia,
anorexia,
and
social
and
neurodevelopmental retardation were the most
common symptoms present in patients. Seizures were
observed in 12 (28.5%) infants. The seizures in 10
patients were generalized tonic-clonic, 1 was focal,
and 1 was absence. These patients were treated with
midazolam (0.1 mg/kg slow bolus intravenous), and
then oral anticonvulsants were given; the seizures did
not repeat. The presenting neurological symptoms
and signs of the hypotonic babies are shown in Table 1.

Anemia was present in 35 (83.3%),
thrombocytopenia in 12 (28.5%), leukopenia in 7
(16.6%), and pancytopenia in 5 (11.9%) infants.
Hypersegmentation, macrocytosis, and anisocytosis
were observed in 34 infants (80.9%). Mean MCV was
87.2 ± 8.8 fL. Peripheral blood examinations of all
patients were compatible with megaloblastic changes.
The mean serum vitamin B12 and homocysteine
levels of infants were shown in Table 2.
Hyperhomocysteinemia was detected in 33 (78.5%)
patients. Of the 22 mothers for whom serum vitamin
B12 measurement could be made, 21 had low serum
vitamin B12 (Table 2). No folic acid deficiency or
proteinuria was detected in our patients.
Vitamin B12 treatment was started immediately
in all the patients with a diagnosis of megaloblastic
anemia due to vitamin B12 deficiency. Blood values
had improved by the second week of treatment. For
the treatment, dietary management and parenteral
vitamin B12 (50-100 μg/day IM for the first 2 weeks,
then monthly) were given. In all patients rapid
clinical improvement was observed after vitamin
B12 administration. Follow-up visits were regularly
attended by 73.8% (31/42) of patients. Normal scores
on the Denver-II Development Screening Test were
achieved by 14 patients 2 months after the treatment;
however, 17 had delayed neurologic development.
The measurement of serum vitamin B12 levels
was required in 18 (18/31) patients, and the mean
level was 623.1 ± 320.1 pg/mL. Other patients
achieved remission within 6 months. Long-term
developmental assessment after treatment could not
be done because some of the patients did not come to
their follow-up regularly.

Table 1. Presenting neurological symptoms of the patients with nutritional vitamin B12 deficiency.
Neurological symptom
Hypotonia
Anorexia
Neurodevelopmental retardation
Social retardation
Weakness
Seizure
Athetoid head movement
Apathy
Tremor
Fasciculation

Number of patients (n)

%

42
39
36
34
28
12
8
6
4
2

100
92.8
85.7
80.9
66.6
28.5
19.0
14.2
9.5
4.7

1093

Neurological findings of vitamin B12 deficiency

Table 2. Laboratory results of patients with vitamin B12 deficiency.
Parameters
WBC (/mm³)
Hemoglobin (g/dL)
Platelet (×10³/mm³)
MCV (fL)
Homocysteine (mmol/L)
B12 (infants) (pg/mL)
B12 (mothers) (pg/mL)

Mean ± SD

Range

10.5 ± 3.9
10.8 ± 1.1
284.6 ± 154.8
87.2 ± 8.8
15.4 ± 4.7
142.7 ± 46.3
159.6 ± 31.4

4.0-17.5
9.4-12.0
89-551
72-109
6.9-24
30-190
67-196

Hb: hemoglobin; WBC: white blood cell; Plt: platelet count;
MCV: mean corpuscular volume.

Discussion
The most important cause of vitamin B12
deficiency in infants is low intake of animal protein
by the lactating mother together with complete
dependence on breast milk. Vitamin B12 deficiency
generally occurs in young children (<2 years of age)
from groups with low socio-economic status, and the
main cause is inadequate intake either from the diet
or breast milk (11).

Koc et al., in a study conducted in our region,
found vitamin B12 deficiency (<160 pg/mL) in 72%
of the mothers and 41% of the babies, and severe
deficiency (<120 pg/mL) in 48% of the mothers and
23% of the babies. In that study, folate deficiency was
found in 12% of the mothers, but was not found in
any of the babies (9). In our study, all of the infants
had low vitamin B12 and no folate deficiency.

In the study by Chandra et al. (12) 51 subjects
with megaloblastic anemia were evaluated. In that
study the mean age was 18 months (6-132), and
60.8% of the subjects were below 2 years of age. In
another study involving 200 children between 18 and
36 months by Allen et al., prevalence of megaloblastic
anemia was reported as 8%, and poor nutrition was
reported as a risk factor attributed to megaloblastic
anemia (13). In our study all infants were below 2
years of age, and the mean age of infants was 13.0 ±
5.6 months. Most of the infants were only breastfed
and were of low socio-economical and cultural
status. Twenty-nine infants (69%) were below the 3rd
percentile for their age.

Neurological symptoms and signs of vitamin
B12 deﬁciency such as nausea, lethargy, irritability,
unhappiness, hypotonia, apathy, neuromotor
developmental delay, nutritional disorders, and
convulsions may be seen (10,15). Approximately half
of the infants have abnormal movements including
tremor, myoclonus, and choreoathetoid movements
(17). In the study by Katar et al. (10) the most
frequently reported clinical signs and symptoms
were paleness, hypoactivity, attention deficit, and
stomatitis. All of our patients had hypotonia,
and anorexia, seizures, weakness, and social and
neurodevelopmental retardation were the most
common symptoms in all infants. Athetoid head
movements were observed in 8 patients, and 4 had
tremors that disappeared during sleep.

During pregnancy vitamin B12 is actively
transported to the fetus by the placenta and reaches
twice the level of maternal serum (14). Neonatal
vitamin B12 stores are generally enough for about
6-12 months in a normal infant (15). If not diagnosed
and treated, infants born with low vitamin B12 stores
may show irreversible psychomotor retardation and
severe neurological problems within the first years of
life (9,16).

Vitamin B12 deficiency may lead to serious
hematological problems in addition to anemia.
Thrombocytopenia and neutropenia are also
important problems. In a study involving 15 children
between 7 and 18 months by Incecik et al. anemia was
reported in all, thrombocytopenia in 7, leukopenia in
5, and pancytopenia in 4 (15). Among our patients
83.3% had anemia, 28.5% had thrombocytopenia,
16.6% had leukopenia, and 11.9% had pancytopenia.
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Early diagnosis and treatment is very important in
cases of hematological complications and neurologic
impairment. Dietary treatment and intramuscular
vitamin B12 (25-100 μg/day for young children and
250-1000 μg/day for older children; initially, every
day for 3 or 7 days and then monthly) are important
in cases of nutritional vitamin B12 deficiency (8,15).
In our study vitamin B12 and/or dietary treatments
were started immediately in all patients in whom
blood values improved by the second week of
treatment.
Limitations of the study
Serum vitamin B12 levels could not be measured
in all mothers, and not all patients could be followedup regularly. The low number of participants and
records from a single center may be the limitations of
the present study, but data are still valuable and may
be used by other centers for further investigations.
The topic of this study is important as nutritional
vitamin B12 deficiency is a public health problem in
Southeast Turkey.

In conclusion, nutritional vitamin B12 deficiency
continues to be an important health problem in our
region, as suggested by previous studies. Inadequate
intake of animal products, exclusive use of breast
milk for feeding during the first 1 or 2 years of
life, and low socio-economic background play an
important role in the development of this condition.
Low socio-cultural levels of the mothers, inadequate
health advice, and misinformation about feeding—
such as starting complementary food later—may
be important reasons for vitamin B12 deficiency in
infants. A delay in diagnosis and treatment may cause
neurological and mental problems. Early diagnosis
and treatment of vitamin B12 deficiency is crucial for
long-term prognosis. Vitamin B12 supplementation
of mother and child can prevent neurological
symptoms in the baby. The neurological symptoms
of infants with manifest vitamin B12 deficiency are
reversible with early treatment.
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